LeadStory

CNBC

AstraZeneca reportedly looks to move its listing across the Atlantic

CNBC · Less Recent
CNBC
CNBC
Less Recent

The Times reports that AstraZeneca, the U.K.'s most valuable public company, is looking to move its listing from London to the U.S.

BreakdownGenerated by LeadStory AI
  • AstraZeneca is reportedly considering moving its listing from London to the US.
  • CEO Pascal Soriot is said to be driving the potential move. 11s
  • AstraZeneca is the UK's most valuable public company, making up a significant portion of the FTSE 100. 17s
  • Key factors include valuation differences, tax regimes, and regulatory challenges in the UK. 1m 16s
  • The company is reportedly frustrated with UK restrictions on new medicine approvals. 1m 57s
Business